Scholarly Index

Gary J. Nabel

OPKO Health (United States); 59,309 total citations; 456 total publications; best world rank #34

OPKO Health (United States)

59,309Total citations

456Total publications

133H-index

Published ranking records

Field	Window	World rank	National rank	Impact score
Immunology	Lifetime	251	US 129	99.38
Virology	Lifetime	37	US 31	99.41
Epidemiology	Lifetime	958	US 485	98.71
Infectious Diseases	Lifetime	436	US 225	98.38
Genetics	Lifetime	811	US 421	98.01
Cancer Research	Lifetime	921	US 465	92.93
HIV Research and Treatment	Lifetime	34	US 31	99.83
Virus-based gene therapy research	Lifetime	55	US 47	99.72
Immune Cell Function and Interaction	Lifetime	193	US 121	99.74
RNA Interference and Gene Delivery	Lifetime	190	US 100	99.36
vaccines and immunoinformatics approaches	Lifetime	35	US 22	99.44
Viral Infections and Outbreaks Research	Lifetime	64	US 35	99.18
SARS-CoV-2 and COVID-19 Research	Lifetime	281	US 108	98.93
Immunotherapy and Immune Responses	Lifetime	372	US 193	99.35
NF-κB Signaling Pathways	Lifetime	74	US 33	99.06
T-cell and Retrovirus Studies	Lifetime	73	US 35	98.87
CRISPR and Genetic Engineering	Lifetime	478	US 269	98.33
Hepatitis B Virus Studies	Lifetime	626	US 199	98.39
Influenza Virus Research Studies	Lifetime	367	US 169	98.27
CAR-T cell therapy research	Lifetime	647	US 384	98.23
Herpesvirus Infections and Treatments	Lifetime	881	US 480	96.45
interferon and immune responses	Lifetime	793	US 328	95.68
Virology and Viral Diseases	Lifetime	836	US 367	94.61